Sieta T. de Vries
University Medical Center Groningen
Internal medicineCross-sectional studySurvey researchPhysical therapyAdverse effectCohort studyYoung adultType 2 diabetesDiseaseMEDLINEDrugPrimary careDrug reactionRisk communicationIn patientHealth professionalsMedical educationFamily medicineSocial mediaDiabetes mellitusPharmacovigilanceClinical psychologyMedicineBlood pressure
35Publications
11H-index
234Citations
Publications 38
Newest
#1Martina Ambrož (UMCG: University Medical Center Groningen)
#2Sieta T. de Vries (UMCG: University Medical Center Groningen)H-Index: 11
Last. Petra Denig (UMCG: University Medical Center Groningen)H-Index: 28
view all 4 authors...
Background and Aims: Low systolic blood pressure (SBP) levels while being treated with antihypertensives may cause hypotension-related adverse events (hrAEs), especially in the elderly, women, and frail patients. We aimed to assess the association between the occurrence of hrAEs and low SBP levels, age, sex, and polypharmacy among patients with type 2 diabetes (T2D) treated with antihypertensives. Methods: In this cohort study, we used the Groningen Initiative to ANalyse Type 2 diabetes Treatmen...
Source
Source
#1Sieta T. de Vries (UMCG: University Medical Center Groningen)H-Index: 11
#2Petra Denig (UMCG: University Medical Center Groningen)H-Index: 28
Last. Peter G. M. Mol (UMCG: University Medical Center Groningen)H-Index: 21
view all 7 authors...
INTRODUCTION Healthcare professionals (HCPs) and patients have various motives to report adverse drug reactions (ADRs) to their national agency. These motives may differ between countries. OBJECTIVE The aim of this study was to assess to what extent motives of HCPs and patients to report ADRs differ between countries. METHODS HCPs and patients from Croatia (HR), The Netherlands (NL), and the UK were asked to complete a web-based survey containing questions regarding demographics and ADR reportin...
Source
#1Carla J. Jonker (UU: Utrecht University)H-Index: 2
#2Sieta T. de Vries (UMCG: University Medical Center Groningen)H-Index: 11
Last. Peter G. M. Mol (UMCG: University Medical Center Groningen)H-Index: 21
view all 6 authors...
INTRODUCTION In rare diseases, registry-based studies can be used to provide natural history data pre-approval and complement drug efficacy and/or safety knowledge post-approval. OBJECTIVE The objective of this study was to investigate the opinion of stakeholders about key aspects of rare disease registries that are used to support regulatory decision making and to compare the responses of employees from industry to other stakeholders. METHODS A web-based survey was used to gauge the importance ...
Source
#1Elisabeth Bakker (UMCG: University Medical Center Groningen)
#4Thorsten VetterH-Index: 7
Last. Michelle J. PenaH-Index: 11
view all 15 authors...
Aim This study aimed to identify from different stakeholders the benefits and obstacles of implementing precision medicine in diabetic kidney disease (DKD) and to build consensus about a way forward in order to treat, prevent, or even reverse this disease. Methods As part of an ongoing effort of moving implementation of precision medicine in DKD forward, a two-day consensus-building meeting was organized with different stakeholders involved in drug development and patient care in DKD, including ...
Source
We assessed sex differences across the life span in the lipid profile of type 2 diabetes (T2D) patients treated and not treated with statins. We used the Groningen Initiative to ANalyze Type 2 diabetes Treatment database, which includes T2D patients from the north of the Netherlands. Patients with a full lipid profile determined between 2010 and 2012 were included. We excluded patients treated with other lipid-lowering drugs than statins. Sex differences in low- and high-density lipoprotein chol...
1 CitationsSource
This study assessed to what extent women were included in all phases of drug development; whether the clinical studies in the marketing authorization application dossiers include information per sex; and explored whether there are differences between women and men in the drugs' efficacy and safety. Data were extracted from dossiers submitted to the European Medicines Agency. Twenty-two dossiers of drugs approved between 2011 and 2015 for the treatment of various diseases were included. Female an...
Source
#1Sonia Roldan Munoz (UMCG: University Medical Center Groningen)H-Index: 1
#2Douwe Postmus (UMCG: University Medical Center Groningen)H-Index: 24
Last. Peter G. M. Mol (UMCG: University Medical Center Groningen)H-Index: 21
view all 7 authors...
Objective: The aim of this study was to compare the importance that patients with type 2 diabetes mellitus from the Netherlands and Turkey attach to certain drug effects of oral anti-diabetic drugs. Methods: Data were collected through a cross-sectional survey containing demographic questions and a discrete choice experiment assessing preferences for oral anti-diabetic drugs. Adults from the Netherlands and Turkey were included if they had type 2 diabetes mellitus and had received a prescription...
Source
#1Martina Ambrož (UMCG: University Medical Center Groningen)
#2Sieta T. de Vries (UMCG: University Medical Center Groningen)H-Index: 11
Last. Petra Denig (UMCG: University Medical Center Groningen)H-Index: 28
view all 4 authors...
Aims: Less strict glycated hemoglobin (HbA1c) thresholds have been recommended in older and/or frail type 2 diabetes (T2D) patients than in younger and less frail patients for initiating hypoglycemic agents since 2011. We aimed to assess trends in HbA1c thresholds at initiation of a first hypoglycemic agent(s) in T2D patients and the influence of age and frailty on these trends. Materials and methods: The groningen initiative to analyze type 2 diabetes treatment (GIANTT) database was used, which...
Source
#1Martina Ambrož (UG: University of Groningen)
#2Sieta T. de Vries (UG: University of Groningen)H-Index: 11
Last. Petra Denig (UG: University of Groningen)H-Index: 28
view all 5 authors...
Objective To assess trends in systolic blood pressure (SBP) thresholds at initiation of antihypertensive treatment in patients with type 2 diabetes and the impact of age and frailty on these trends. Study design and setting A repeated cross-sectional cohort study (2007–2014) using the Groningen Initiative to Analyse Type 2 diabetes Treatment database was conducted. The influence of calendar year, age or frailty and the interaction between year and age or frailty on SBP thresholds were assessed u...
Source